|
|
8:15 - 8:45 a.m. |
Registration, Continental Breakfast |
|
8:45 a.m. |
Welcome
Theodore G. Krontiris, M.D., Ph.D., Executive Vice President for Scientific and Medical Affairs |
|
8:50 - 9:00 a.m. |
Epigenetics: A Historical Overview
Arthur D. Riggs, Ph.D., Director, Beckman Research Institute |
| 9:00 - 9:50 a.m. |
Site Specific Usage of Histone Acetylation Sites Regulates Transcription
Michael Grunstein, Ph.D., UCLA School of Medicine |
| 9:50 - 10:40 a.m. |
The Role of Histone Methylation in Gene Expression and Cancer
Yi Zhang, Ph.D., University of North Carolina |
| 10:40 - 11:00 a.m. |
Break
|
| 11:00 - 11:50 p.m. |
Polycomb Repressors Controlling Stem Cell Fate: Implications for Cancer and Development
Maarten van Lohuizen, Ph.D., The Netherlands Cancer Institute |
| 11:50 - 1:00 p.m. |
Lunch |
| 1:00 - 1:50 p.m. |
Epigenetic Patterns Generated by Histone Replacement
Steven Henikoff, Ph.D., Fred Hutchinson Cancer Research Center |
| 1:50 - 2:40 p.m. |
X-Chromosome Inactivation: Sex, Heterochromatin, Pairing, and Noncoding RNA
Jeannie T. Lee, M.D., Ph.D., Massachusetts General Hospital |
| 2:40 - 3:00 p.m. |
Break |
| 3:00 - 3:50 p.m. |
Chromatin State Maps of Pluripotent and Lineage-Committed Cells
Bradley E. Bernstein, M.D., Ph.D., Massachusetts General Hospital |
| 3:50 - 4:40 p.m. |
Epigenetic Therapies
Peter A. Jones, Ph.D., USC / Norris Comprehensive Cancer Center |
|